Additionally, further exploration of the biological mechanisms underlying RB progression is necessary, particularly to determine if NR1D1 and NR2E3 serve as early indicators of more aggressive RB or if these genes are downregulated as the tumor grows. This evidence concerns the gene NR1D1 and neoplasm.